Richard Kinh Gian Do, MD, PhD

About Me

I am a radiologist who specializes in body imaging. My expertise is in imaging for liver cancer, bile duct cancer, and pancreatic cancer. I help oncologists make the best decisions possible for treating hepatopancreatobiliary cancers. From diagnosis and staging to treatment response, I am committed to delivering accurate and actionable reports for the care of people with cancer. While I have been practicing at MSK for nearly a decade, my goal is to continuously improve diagnosis and treatment through active research.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

My research interests are in advanced CT and MRI techniques for hepatopancreatobiliary tumors. I also work with computer scientists to investigate the potential of computer-based medical image analysis. This approach, also known as radiomics, lets us look at medical images beyond what the human eye can see. Medical images contain a vast amount of hidden data. We are harnessing this big data to predict tumor pathology, genetics, and response to treatment.

I am active in the American College of Radiology. Together with other radiologists, I am developing new guidelines for treatment response assessment for hepatocellular carcinoma and other liver tumors. I frequently lecture on hepatopancreatobiliary tumors at meetings for the Radiological Society of North America and the International Society for Magnetic Resonance in Medicine. Finally, as MRI Safety Officer at MSK, I lead a team of doctors, nurses, managers, and radiology technologists to ensure the complete safety of people with cancer and staff members in the MRI environment.

  • Clinical Expertise: Abdominal Radiology
  • Languages Spoken: English
  • Education: MD, Weill Cornell Medical College; PhD, Weill Cornell Graduate School of Medical Sciences
  • Residencies: NYU Langone Medical Center
  • Fellowships: NYU Langone Medical Center
  • Board Certifications: Diagnostic Radiology

New Patient Appointments

Making an appointment

Call 800-525-2225

See My Colleagues

Publications

Sadot E, Simpson AL, Do RK, Gonen M, Shia J, Allen PJ, D’Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR. Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes. PLoS One. 2015 Jul 24;10(7):e0132953

Simpson AL, Adams LB, Allen PJ, D’Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Leung U, Miga MI, Parada EP, Jarnagin WR, Do RK. Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. J Am Coll Surg. 2015 Mar;220(3):339-46

Konstantinidis IT, Do RK, Gultekin DH, Gönen M, Schwartz LH, Fong Y, Allen PJ, D’Angelica MI, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Ann Surg Oncol. 2014 Aug;21(8):2675-83

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Insurance

Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more